biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > BTI.H delisted from NEX

<< Previous

Bullboard Posts

Next >>

Post by MineDiggeron Dec 24, 2024 4:51am

92 Views

Post# 36376021

BTI.H delisted from NEX

"Effective at the close of business Tuesday, Dec. 24, 2024, and in accordance with NEX Policy, Section 15, securities of the company will be delisted from NEX, for failure to pay its quarterly NEX listing maintenance fees. Prior to delisting, the shares of the company were subject to suspension from trading. "

taken from Stockwatch, paywalled I think,. https://www.stockwatch.com/News/Item/Z-C!BTI-3636645/C/BTI

Are we still waiting for JD to tell us that we can take this as a loss, despite not having crystallised it by selling!?

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week